Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cubist Pharmaceuticals Announces Senior Executive Appointments

Published: Tuesday, July 03, 2012
Last Updated: Tuesday, July 03, 2012
Bookmark and Share
Robert J. Perez, currently Executive Vice President and Chief Operating Officer (COO), has been named President and COO.

Michael Tomsicek, currently Vice President of Corporate Finance, has been named Senior Vice President and Deputy Chief Financial Officer. In addition, Thomas Rollins has been appointed Senior Vice President of Program and Portfolio Management.

"As we recently articulated in our Building Blocks of Growth strategic goals, attracting, retaining and developing top talent are critical to growing and expanding our business on a global basis, and I am delighted today to announce these senior appointments," said Michael Bonney, Chief Executive Officer.

"Rob and Mike are exceptional leaders who have made significant contributions to our recent operational and financial success, and we're pleased to have them take on added responsibilities. We're also delighted that Tom will join our senior Cubist leadership team, adding strengths across all phases of our product development process."

In Mr. Perez's role as President and COO, he will oversee all global commercial, manufacturing, business development, and information technology functions. In this capacity, he will have responsibility for overseeing Cubist's international business expansion. Mr. Perez has been EVP and COO since 2007. He joined Cubist in 2003 as Senior Vice President of Cubist's sales and marketing team and then served as SVP of Commercial Operations from 2004 to 2007. Prior to joining Cubist, he spent eight years at Biogen Idec, where he most recently served as Vice President of the company's CNS Business Unit. From 1987 to 1995, Mr. Perez held various sales and marketing positions at Zeneca Pharmaceuticals, including serving as Regional Business Director.

In Mr. Tomsicek's new role as SVP and Deputy CFO, he will oversee all financial planning and analysis, technical accounting, controllership, treasury, tax, commercial financial services, and strategic sourcing activities, reporting to David McGirr, Chief Financial Officer. Mr. Tomsicek joined Cubist in 2010. Prior to Cubist, he spent eight years at General Electric Healthcare, initially as global operations Finance Manager for its Monitoring business, and then as CFO of its diagnostic ultrasound business and CFO of its global ultrasound product group. Previously, Mr. Tomsicek served in a variety of financial and channel management roles at Motorola.

Mr. Rollins joins Cubist from Sunovion Pharmaceuticals, Inc., a subsidiary of Dainippon Sumitomo Pharmaceuticals Inc., where he has been SVP of Program Management and R&D Planning since 2009. He spent 15 years at Sepracor Inc. most notably serving as Vice President of Development Operations from 2001-2005 and Senior Vice President of Product Development from 2005-2009. Prior to Sepracor, he held numerous senior research and project positions at Merck Research Laboratories.

As SVP of Program and Portfolio Management at Cubist, Mr. Rollins will be responsible for maximizing the value of Cubist products and product candidates on a global basis. He will report to Steven Gilman, Cubist's Executive Vice President, Research & Development and Chief Scientific Officer.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Vital Protein in Healthy Fertilization Process Identified
Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!